Wellmedr vs Oak Longevity: pricing, delivery, and review speed
Quick verdict: Wellmedr vs Oak Longevity favors Wellmedr for lower advertised starting prices and lifetime locked pricing, while Oak Longevity emphasizes a flat one-price policy and no subscriptions. This comparison uses only the supplied facts and highlights pricing, pricing structure, shipping and review speed, regulatory notes, and what each provider includes.
See Wellmedr plans starting at $89/month
How pricing and pricing structure compare
The most obvious difference in Wellmedr vs Oak Longevity is advertised starting price and how prices are structured. Wellmedr advertises GLP-1 plans starting at $89/month and lists semaglutide monthly plans starting at $49 a month in landing-page text, with promotional language about Labor Day Sale and other offers. Wellmedr also promotes lifetime locked-in pricing and no dose-based price increases. Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month, and promotes one flat price that covers all dosages with no tier-based pricing.
View Oak Longevity semaglutide from $133/month
What is included: subscriptions, coaching, and shipping
Wellmedr markets same-day review plus free overnight shipping and on-time refills guaranteed for monthly plans with options to cancel or change anytime. Oak Longevity emphasizes no subscriptions, no membership fees, free health coaching, free shipping with tracking, and billing monthly on a non-recurring basis so you are not auto charged.
Check Wellmedr shipping and refill options
Clinical review process and availability
In this Wellmedr vs Oak Longevity comparison, both require clinician review and state availability checks. Wellmedr notes that all treatment plans require medical evaluation and clinician approval and that treatment is available only when a licensed clinician determines it is medically appropriate. Oak Longevity states a licensed physician reviews your information, that board-certified physicians in your state review every case, and that no video call is required because the clinical review is asynchronous.
Regulatory and safety notes
Both providers offer compounded GLP-1 medications and include the regulatory qualifier that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr’s landing-page evidence explicitly states that compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy. Oak Longevity also states its compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies and repeats that compounded medications are not FDA-approved.
Distinctive supported differences
This section highlights the three to five most distinctive differences supported by the source for Wellmedr vs Oak Longevity.
- Advertised starting price: Wellmedr lists GLP-1 plans starting at $89/month and semaglutide monthly plans starting at $49 a month in landing-page text. Oak Longevity lists semaglutide starting at $133/month and tirzepatide at $199/month.
- Pricing model: Wellmedr promotes lifetime locked-in pricing and no dose-based price increases. Oak Longevity promotes one flat price for all dosages and no subscriptions or membership fees, billed non-recurring monthly.
- Included services: Wellmedr highlights same-day review plus free overnight shipping and on-time refills. Oak Longevity includes free health coaching, free shipping with tracking, and same-day approval available for qualifying patients.
- Clinical process: Oak Longevity explicitly states no video call is required and reviews are asynchronous with board-certified physicians in your state. Wellmedr confirms medical evaluation and clinician approval but captured evidence does not specify asynchronous review or video requirements beyond same-day review.
Comparison table: direct side-by-side
| Criteria | Wellmedr | Oak Longevity |
|---|---|---|
| Advertised semaglutide starting price | Semaglutide from $49/month mentioned; GLP-1 plans from $89/month | Semaglutide from $133/month |
| Tirzepatide starting price | Tirzepatide starting at $89/month listed for monthly plan | Tirzepatide from $199/month |
| Pricing structure | Lifetime locked-in pricing; no dose-based price increases | One price covers all dosages; no subscriptions |
| Shipping and refills | Free overnight shipping; on-time refills guaranteed | Free shipping with tracking; same-day approval available |
| Clinical review | Same-day review claimed; all plans require clinician approval | Asynchronous review by board-certified physicians in your state; no video call required |
| Regulatory note | Offers compounded GLP-1 medications; compounded meds not FDA-approved | Compounded semaglutide and tirzepatide from licensed compounding pharmacies; compounded meds not FDA-approved |
Final comparison and recommendation
In the Wellmedr vs Oak Longevity comparison, choose based on price model and included services. Wellmedr is presented as lower starting prices and lifetime locked-in pricing plus same-day review and overnight shipping. Oak Longevity is presented as a one-price-for-all-dosages approach with no subscriptions, free health coaching, and non-recurring monthly billing.
Choose Wellmedr if you prioritize the lowest advertised starting price and lifetime locked-in pricing plus same-day review and overnight shipping.
Choose Oak Longevity if you prefer one flat price for all dosages, no subscription model, free health coaching, and asynchronous review by board-certified physicians in your state.